Casey Ross

Investigative reporter Casey Ross reveals how UnitedHealth Group used an algorithm to deny patient care for profit. Biotech veteran Michael Gilman talks about being a startup CEO in the economic downturn and shares cocktail recipes. They also discuss the approval of a groundbreaking CRISPR-based medicine.

Casey Ross, a reporter at the intersection of technology and healthcare, and Bob Herman, a journalist specializing in healthcare and business, dive into the complex role of AI in determining medical coverage. They discuss the troubling case of Frances Walter, showcasing how automated decisions can jeopardize vulnerable patients. The conversation highlights the tensions between AI efficiency and personalized care, raising ethical concerns about transparency and accountability in healthcare. Their insights urge a critical look at AI's growing influence on patient welfare.

Casey Ross, AI correspondent and Pulitzer finalist, discusses AI-centered drug discovery with NVIDIA and Isomorphic Labs at STAT's Breakthrough Summit West. Other topics include obesity drug data from Roche, Novartis' acquisition of MorphoSys, and the AI revolutionizing drug discovery.